AXONIS Therapeutics
Linda Jones has held various positions in the field of healthcare since 2002. Linda began their career as a Clinical Trial Manager for Proneuron Biotechnologies in 2002. In 2006, they moved to Geron Corporation in the same role. In 2012, they became a Clinical Research Consultant for an independent company. In 2018, they were a Research Consultant for an independent company. In 2019, they became Collaborating Faculty at Thomas Jefferson University. Currently, they are the Consultant Director of Translation at AXONIS Therapeutics.
Linda Jones completed their Doctor of Philosophy - PhD in Clinical Science from the University of Colorado Anschutz Medical Campus in 2020. Prior to this, they earned an M.S. in Neurological Physical Therapy from Samuel Merritt University, a B.S. in Physical Therapy from the University of Colorado Anschutz Medical Campus, and a B.S. in Kinesiology from the University of Colorado Boulder.
This person is not in any teams
This person is not in any offices
AXONIS Therapeutics
AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system.